ArticlePediatric nephrology (Berlin, Germany)2026
Comparing outcomes with different dialysis modalities in children with kidney failure: home hemodialysis versus in-center hemodiafiltration or conventional hemodialysis.
Article in Pediatric nephrology (Berlin, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Adequacy of dialysis in children and adolescents: more than just Kt/V.Pediatric nephrology (Berlin, Germany) · 2026Review
- Dialysis-associated cardiovascular disease risk in children: mechanism and management.Pediatric nephrology (Berlin, Germany) · 2026Review
- Is home best when it comes to pediatric hemodialysis?Pediatric nephrology (Berlin, Germany) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
34 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHome hemodialysis (HHD) and hemodiafiltration (HDF) have independently shown superior cardiovascular outcomes compared with conventional hemodialysis (HD) in adults, but pediatric data are scarce. We compared outcomes on HHD, HDF and HD therapies in children.
methodsSingle-center data from HHD patients over 13 years were compared with the multicenter prospective "3H - HDF, Heart and Height" study. Systolic blood pressure [SBP] standard deviation score [SDS], left ventricular mass index [LVMI], height-SDS, biochemical markers, dialysis-related symptoms and medication burden were compared within the HHD cohort and between the three dialysis modalities at baseline and 12 months.
resultsAmong 38 HHD patients with complete follow-up, there were no improvements in SBP-SDS, LVMI or height-SDS over 12 months. Serum phosphate levels decreased (median difference -0.15 mmol/L [95% CI -0.5 to -0.1]; p = 0.002) and hemoglobin increased (+ 1.1 g/dL [95% CI 0.3 to 2.0]; p = 0.01). Comparing 38 HHD patients to 55 HDF and 78 HD patients, SBP-SDS, LVMI, and height-SDS were comparable between HHD and HDF at 12 months. LVMI was lower in HHD compared with HD (-11.8 g/m
conclusionsIn pediatric patients, HHD and HDF showed comparable outcomes for cardiovascular burden, growth, and dialysis-related symptoms, and both demonstrated superior clinical outcomes compared with conventional HD.
Indexed as
Identifiers
40794175What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.